Published in Virchows Arch on January 01, 2011
Serrated neoplasia-role in colorectal carcinogenesis and clinical implications. Nat Rev Gastroenterol Hepatol (2015) 1.00
Double immunohistochemistry enhances detection of lymphatic and venous invasion in early-stage colorectal cancer. Virchows Arch (2015) 0.78
The Grand Challenges in GI Tract Cancers. Front Oncol (2011) 0.75
The Natural History of pT1 Colorectal Cancer. Front Oncol (2012) 0.75
CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A (1999) 13.02
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology (2007) 7.16
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut (2008) 6.26
Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology (2008) 5.19
Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A (2007) 4.16
CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J Mol Diagn (2006) 3.98
Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol (1990) 3.89
Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc Natl Acad Sci U S A (2000) 3.65
Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol (2003) 3.59
Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn (2007) 3.56
A new prognostic classification of rectal cancer. Lancet (1987) 3.56
Serrated adenomatous polyposis in humans. Gastroenterology (1996) 3.30
Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol (2005) 3.29
Molecular classification and correlates in colorectal cancer. J Mol Diagn (2007) 3.25
High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology (2006) 3.24
Perineural invasion in cancer: a review of the literature. Cancer (2009) 3.06
Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol (2003) 3.05
Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol (2009) 3.04
Pathology of colorectal adenomas: a colonoscopic survey. J Clin Pathol (1982) 2.89
Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology (2004) 2.66
Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum (2002) 2.45
Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology (1985) 2.44
Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol (2008) 2.30
Hyperplastic polyposis: association with colorectal cancer. Am J Surg Pathol (2001) 2.10
Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc (2008) 2.09
Diagnostic criteria for gastrointestinal carcinomas in Japan and Western countries: proposal for a new classification system of gastrointestinal epithelial neoplasia. J Gastroenterol Hepatol (2000) 2.01
Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology (2010) 1.95
Review of histological classifications of gastrointestinal epithelial neoplasia: differences in diagnosis of early carcinomas between Japanese and Western pathologists. J Gastroenterol (2001) 1.93
Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am (2007) 1.88
[Update S3-guideline "colorectal cancer" 2008]. Z Gastroenterol (2008) 1.81
Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer. Histopathology (2006) 1.78
Serrated polyps and colorectal cancer: new pathway to malignancy. Annu Rev Pathol (2009) 1.69
Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med (2009) 1.67
Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma. Clin Cancer Res (2008) 1.64
Tumor budding as an index to identify high-risk patients with stage II colon cancer. Dis Colon Rectum (2008) 1.61
APC mutations and other genetic and epigenetic changes in colon cancer. Mol Cancer Res (2007) 1.54
Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol (2009) 1.47
Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology (2005) 1.43
Flat adenomas of the colon. Hum Pathol (1991) 1.43
Endoscopically removed malignant colorectal polyps: clinicopathologic correlations. Gastroenterology (1995) 1.42
Sessile serrated adenomas with low- and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions "caught in the act". Am J Clin Pathol (2006) 1.36
Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps. Am J Surg Pathol (2008) 1.35
Hyperplastic polyposis and the risk of colorectal cancer. Dis Colon Rectum (2004) 1.25
Progression of a sessile serrated adenoma to an early invasive cancer within 8 months. Dig Dis Sci (2008) 1.20
Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology (1995) 1.20
My approach to serrated polyps of the colorectum. J Clin Pathol (2004) 1.19
CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci. Mod Pathol (2008) 1.16
Serrated polyps of the colorectum: is sessile serrated adenoma distinguishable from hyperplastic polyp in a daily practice? Virchows Arch (2007) 1.15
[Forms and nomenclature of gastrointestinal epithelial expansion: what is invasion?]. Verh Dtsch Ges Pathol (2000) 0.99
Clinicopathologic and endoscopic features of colorectal serrated adenoma: differences between polypoid and superficial types. Gastrointest Endosc (2004) 0.99
Serrated colorectal polyps: emerging evidence suggests the need for a reappraisal. Adv Anat Pathol (2004) 0.96
Selective expression of gastric mucin MUC6 in colonic sessile serrated adenoma but not in hyperplastic polyp aids in morphological diagnosis of serrated polyps. Mod Pathol (2008) 0.95
Observer agreement in the diagnosis of serrated polyps of the large bowel. Histopathology (2009) 0.93
Tumor-cell dissociation at the invasion front: a new prognostic parameter in gastric cancer patients. Int J Cancer (1992) 0.93
Perineural invasion: correlation with aggressive phenotype and independent prognostic variable in both colon and rectum cancer. J Clin Oncol (2010) 0.90
Early colorectal cancer with special reference to the superficial nonpolypoid type from a histopathologic point of view. World J Surg (2000) 0.90
Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths. Scand J Gastroenterol (2009) 0.89
Endoscopic appearance of serrated adenomas in the colon. Endoscopy (2005) 0.89
Tumor budding and survival after potentially curative resection of node-positive colon cancer. Dis Colon Rectum (2010) 0.85
[Risk factors for lymphatic metastasis from pT1 colorectal adenocarcinoma]. Pathologe (2003) 0.80
[Precancerous lesions of the colon and rectum]. Gan To Kagaku Ryoho (1984) 0.76
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol (2006) 5.78
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet (2009) 4.58
Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol (2002) 4.02
A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer. Cancer Discov (2011) 3.86
Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology (2007) 3.78
Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE. J Natl Cancer Inst (2011) 3.75
What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol (2008) 3.21
Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"--SCORE. J Natl Cancer Inst (2002) 3.00
Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst (2005) 2.51
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial. Lancet Oncol (2013) 2.41
Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc (2008) 2.09
HER2 testing and correlation with efficacy of trastuzumab therapy. Oncology (Williston Park) (2002) 1.61
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol (2009) 1.55
Inhibition of MEK and PI3K/mTOR suppresses tumor growth but does not cause tumor regression in patient-derived xenografts of RAS-mutant colorectal carcinomas. Clin Cancer Res (2012) 1.51
Virtual reality microscope versus conventional microscope regarding time to diagnosis: an experimental study. Histopathology (2012) 1.47
Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma. Clin Cancer Res (2006) 1.44
An international, multicentre, prospective, randomised, controlled, unblinded, parallel-group trial of robotic-assisted versus standard laparoscopic surgery for the curative treatment of rectal cancer. Int J Colorectal Dis (2011) 1.44
Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol (2010) 1.42
Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice. J Clin Invest (2010) 1.41
Determinants of successful implementation of population-based cancer screening programmes. Eur J Cancer (2011) 1.33
Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlations. Clin Cancer Res (2011) 1.32
Virtual reality Powerwall versus conventional microscope for viewing pathology slides: an experimental comparison. Histopathology (2009) 1.31
An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice. J Clin Invest (2004) 1.25
A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status. Cancer (2009) 1.23
Cervical cancer screening policies and coverage in Europe. Eur J Cancer (2009) 1.23
Has the new TNM classification for colorectal cancer improved care? Nat Rev Clin Oncol (2011) 1.19
Tracking with virtual slides: a tool to study diagnostic error in histopathology. Histopathology (2009) 1.18
Histologic risk factors and clinical outcome in colorectal malignant polyp: a pooled-data analysis. Dis Colon Rectum (2005) 1.16
Mammographic screening programmes in Europe: organization, coverage and participation. J Med Screen (2012) 1.16
EphB2 is a prognostic factor in colorectal cancer. Clin Cancer Res (2005) 1.11
Expression of DNA double-strand break repair proteins ATM and BRCA1 predicts survival in colorectal cancer. Clin Cancer Res (2006) 1.08
In melanocytic lesions the fraction of BRAF V600E alleles is associated with sun exposure but unrelated to ERK phosphorylation. Mod Pathol (2008) 1.07
Focus on extralevator perineal dissection in supine position for low rectal cancer has led to better quality of surgery and oncologic outcome. Ann Surg Oncol (2011) 1.06
Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy. Histopathology (2012) 1.05
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas. BMC Cancer (2010) 1.04
Altered molecular pathways in melanocytic lesions. Int J Cancer (2010) 1.03
Prediction of the response of colorectal cancer to systemic therapy. Lancet Oncol (2002) 1.03
Working at the microscope: analysis of the activities involved in diagnostic pathology. Histopathology (2011) 1.01
The incidence and survival rates of colorectal cancer in India remain low compared with rising rates in East Asia. Dis Colon Rectum (2012) 1.01
Quality assurance in pathology in colorectal cancer screening and diagnosis—European recommendations. Virchows Arch (2011) 1.00
VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas. Melanoma Res (2005) 1.00
High frequency of MYH gene mutations in a subset of patients with familial adenomatous polyposis. Gastroenterology (2004) 0.99
The growing complexity of the intestinal polyposis syndromes. Am J Med Genet A (2013) 0.97
Cancer screening and health system resilience: keys to protecting and bolstering preventive services during a financial crisis. Eur J Cancer (2012) 0.95
High-resolution array comparative genomic hybridization in sporadic and celiac disease-related small bowel adenocarcinomas. Clin Cancer Res (2010) 0.95
Colorectal tumors: the histology report. Dig Liver Dis (2011) 0.94
Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference. Surg Endosc (2015) 0.93
The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European Consensus. Radiother Oncol (2005) 0.92
Evaluation of 7q31 region improves the accuracy of EGFR FISH assay in non small cell lung cancer. Diagn Pathol (2009) 0.91
Mesorectal fascia instead of circumferential resection margin in preoperative staging of rectal cancer. J Clin Oncol (2011) 0.91
Barrett's esophagus: natural history. Ann N Y Acad Sci (2011) 0.88
APC haploinsufficiency, but not CTNNB1 or CDH1 gene mutations, accounts for a fraction of familial adenomatous polyposis patients without APC truncating mutations. Lab Invest (2003) 0.88
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis. Gastroenterology (2006) 0.84
Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines. J Pathol (2012) 0.84
DNA methylation, a biomarker for colorectal cancer: implications for screening and pathological utility. Ann N Y Acad Sci (2003) 0.83
Chromosomal instability and APC gene mutations in human sporadic colorectal adenomas. J Pathol (2004) 0.83
Surgical treatments for esophageal cancers. Ann N Y Acad Sci (2014) 0.82
Near-diploid and near-triploid human sporadic colorectal adenocarcinomas differ for KRAS2 and TP53 mutational status. Genes Chromosomes Cancer (2003) 0.81
Combined DNA flow cytometry and sorting with k-ras2 mutation spectrum analysis and the prognosis of human sporadic colorectal cancer. Cytometry (2002) 0.81
Germline APC mutation on the beta-catenin binding site is associated with a decreased apoptotic level in colorectal adenomas. Mod Pathol (2003) 0.81
The burden of cervical cancer in south-east Europe at the beginning of the 21st century. Coll Antropol (2007) 0.81
Constitutional high expression of an APC mRNA isoform in a subset of attenuated familial adenomatous polyposis patients. J Mol Med (Berl) (2006) 0.80
Report on the 2007 International Workshop on Human Papillomaviruses and Consensus Recommendations for Cervical Cancer Prevention. Cent Eur J Public Health (2008) 0.80
T3+ and T4 rectal cancer patients seem to benefit from the addition of oxaliplatin to the neoadjuvant chemoradiation regimen. Ann Surg Oncol (2011) 0.79
Oxidative DNA damage drives carcinogenesis in MUTYH-associated-polyposis by specific mutations of mitochondrial and MAPK genes. Mod Pathol (2013) 0.79
Fluorescence in situ hybridization (FISH) evaluation of chromosomes 6, 7, 9 and 10 throughout human melanocytic tumorigenesis. Melanoma Res (2005) 0.79
Piroxicam increases colon tumorigenesis and promotes apoptosis in Mlh1 +/- /Apc1638(N/+) mice. Anticancer Res (2008) 0.79
KRAS transitions and villous growth in colorectal adenomas. Cell Oncol (2005) 0.78
Pathology is a necessary and informative tool in oncology clinical trials. J Pathol (2014) 0.77
Cytogenetic findings in a case of dedifferentiated chondrosarcoma. Cancer Genet Cytogenet (2003) 0.77
Gastrointestinal endoscopy. Preface. Gastrointest Endosc (2008) 0.77
Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumab. Anticancer Drugs (2008) 0.76
A retrospective observational study of length of stay in hospital after colorectal cancer surgery in England (1998-2010). Medicine (Baltimore) (2016) 0.75
Standardization of whole slide image morphologic assessment with definition of a new application: Digital slide dynamic morphometry. J Pathol Inform (2011) 0.75
Insertion of expandable metallic stents in esophageal cancer without fluoroscopy: is it safe? Gastrointest Endosc (2007) 0.75
Nutrition and cancer: a complex relationship. IARC Sci Publ (2002) 0.75
Colonoscopy in screening for colorectal cancer. Arq Gastroenterol (2014) 0.75
Detection of the epidermal growth factor receptor, amphiregulin and epiregulin in formalin-fixed paraffin-embedded human placenta tissue by matrix-assisted laser desorption/ionization mass spectrometry imaging. Eur J Mass Spectrom (Chichester, Eng) (2013) 0.75